Effect of ketamine hydrochloride on the analgesic effects of tramadol hydrochloride in horses with signs of chronic laminitisassociated pain

American Journal of Veterinary Research

Volumn 73, Issue 5, 2012, Pages 610-619

  Guedes, Alonso G P ^a   Matthews, Nora S ^a   Hood, David M ^b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b Hoof Diagnostic and Rehabilitation Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KETAMINE; THROMBOXANE B2; TRAMADOL; TUMOR NECROSIS FACTOR ALPHA;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; BREATHING RATE; CHRONIC LAMINITIS ASSOCIATED PAIN; DRUG DOSE COMPARISON; FEMALE; FOOT PAIN; FORELIMB; HEART RATE; HORSE; INTESTINE SOUND; MALE; MONOTHERAPY; NONHUMAN; RANDOMIZATION; TREATMENT DURATION;

ADMINISTRATION, ORAL; ANALGESICS; ANALGESICS, OPIOID; ANIMALS; CROSS-OVER STUDIES; FEMALE; FOOT DISEASES; HOOF AND CLAW; HORSE DISEASES; HORSES; INJECTIONS, INTRAVENOUS; KETAMINE; MALE; PAIN; TRAMADOL;

ANIMALIA; EQUIDAE;

EID: 84860331859     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.73.5.610     Document Type: Article

References (58)

1. Hood DM. The pathophysiology of developmental and acute laminitis. Vet Clin North Am Equine Pract 1999;15:321-343.
2. Hood DM, Grosenbaugh DA, Mostafa MB, et al. The role of vascular mechanisms in the development of acute equine laminitis. J Vet Intern Med 1993;7:228-234.
3. Parks A, O'Grady SE. Chronic laminitis: current treatment strategies. Vet Clin North Am Equine Pract 2003;19:393-416.
4. Jones E, Vinuela-Fernandez I, Eager RA, et al. Neuropathic changes in equine laminitis pain. Pain 2007;132:321-331.
5. Junger H, Sorkin LS. Nociceptive and inflammatory effects of subcutaneous TNF-α. Pain 2000;85:145-151.
6. Kawasaki Y, Zhang L, Cheng JK, et al. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1β, interleukin-6, and tumor necrosis factor-α in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci 2008;28:5189-5194.
7. Schafers M, Lee DH, Brors D, et al. Increased sensitivity of injured and adjacent uninjured rat primary sensory neurons to exogenous tumor necrosis factor-a after spinal nerve ligation. J Neurosci 2003;23:3028-3038.
8. Schafers M, Svensson CI, Sommer C, et al. Tumor necrosis factor-α induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. J Neurosci 2003;23:2517-2521.
9. Sorkin LS, Xiao WH, Wagner R, et al. Tumour necrosis factor-α induces ectopic activity in nociceptive primary afferent fibres. Neuroscience 1997;81:255-262.
10. Treiber K, Carter R, Gay L, et al. Inflammatory and redox status of ponies with a history of pasture-associated laminitis. Vet Immunol Immunopathol 2009;129:216-220.
11. Buccellati C, Sala A, Ballerio R, et al. Tramadol anti-inflammatory activity is not related to a direct inhibitory action on prostaglandin endoperoxide synthases. Eur J Pain 2000;4:413-415.
12. Cherny NI. The treatment of neuropathic pain: from hubris to humility. Pain 2007;132:225-226.
13. Dworkin RH, O'Connor AB, Backonja M, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007;132:237-251.
14. Driessen B, Reimann W. Interaction of the central analgesic, tramadol, with the uptake and release of 5-hydroxytryptamine in the rat brain in vitro. Br J Pharmacol 1992;105:147-151.
15. Driessen B, Reimann W, Giertz H. Effects of the central analgesic tramadol on the uptake and release of noradrenaline and dopamine in vitro. Br J Pharmacol 1993;108:806-811.
16. Raffa RB, Friderichs E, Reimann W, et al. Opioid and nonopioid components independently contribute to the mechanism of action of tramadol, an 'atypical' opioid analgesic. J Pharmacol Exp Ther 1992;260:275-285.
17. Bianchi M, Martucci C, Ferrario P, et al. Increased tumor necrosis factor-α and prostaglandin E2 concentrations in the cerebrospinal fluid of rats with inflammatory hyperalgesia: the effects of analgesic drugs. Anesth Analg 2007;104:949-954.
18. Kraychete DC, Sakata RK, Issy AM, et al. Proinflammatory cytokines in patients with neuropathic pain treated with tramadol.Rev Bras Anestesiol 2009;59:297-303.
19. Giorgi M, Soldani G, Manera C, et al. Pharmacokinetics of tramadol and its metabolites M1, M2 AND M5 in horses following intravenous, immediate release (fasted/fed) and sustained release single dose administration. J Equine Vet Sci 2007;27:481-488.
20. Sarbu A, Radulescu F, Robertson S, et al. Onset of analgesic effectand plasma levels of controlled-release tramadol (tramadol contramid once-a-day) 200-mg tablets in patients with acute low back pain. J Opioid Manag 2008;4:285-292.
21. Scott LJ, Perry CM. Tramadol: a review of its use in perioperative pain. Drugs 2000;60:139-176.
22. Cox S, Villarino N, Doherty T. Determination of oral tramadol pharmacokinetics in horses. Res Vet Sci 2010;89:236-241.
23. Shilo Y, Britzi M, Eytan B, et al. Pharmacokinetics of tramadol in horses after intravenous, intramuscular and oral administration. J Vet Pharmacol Ther 2008;31:60-65.
24. Craven R. Ketamine. Anaesthesia 2007;62(suppl 1):48-53.
25. Bartoc C, Frumento RJ, Jalbout M, et al. A randomized, doubleblind, placebo-controlled study assessing the anti-inflammatory effects of ketamine in cardiac surgical patients. J Cardiothorac Vasc Anesth 2006;20:217-222.
26. Beilin B, Rusabrov Y, Shapira Y, et al. Low-dose ketamine affects immune responses in humans during the early postoperative period. Br J Anaesth 2007;99:522-527.
27. Kiefer RT, Rohr P, Ploppa A, et al. Efficacy of ketamine in anesthetic dosage for the treatment of refractory complex regional pain syndrome: an open-label phase II study. Pain Med 2008;9:1173-1201.
28. Thomson AM, West DC, Lodge D. An N-methylaspartate receptor- mediated synapse in rat cerebral cortex: a site of action of ketamine? Nature 1985;313:479-481.
29. Wagner AE, Walton JA, Hellyer PW, et al. Use of low doses of ketamine administered by constant rate infusion as an adjunct for postoperative analgesia in dogs. J Am Vet Med Assoc 2002;221:72-75.
30. Wieseler-Frank J, Maier SF, Watkins LR. Immune-to-brain communication dynamically modulates pain: physiological and pathological consequences. Brain Behav Immun 2005;19:104-111.
31. Yang X, Yang HB, Xie QJ, et al. Peripheral inflammation increased the synaptic expression of NMDA receptors in spinal dorsal horn. Pain 2009;144:162-169.
32. Hocking G, Cousins MJ. Ketamine in chronic pain management: an evidence-based review. Anesth Analg 2003;97:1730-1739.
33. Redua MA, Valadao CA, Duque JC, et al. The pre-emptive effect of epidural ketamine on wound sensitivity in horses tested by using von Frey filaments. Vet Anaesth Analg 2002;29:200-206.
34. Subramaniam K, Subramaniam B, Steinbrook RA. Ketamine as adjuvant analgesic to opioids: a quantitative and qualitative systematic review. Anesth Analg 2004;99:482-495.
35. Hood DM, Wagner IP, Taylor DD, et al. Voluntary limb-load distribution in horses with acute and chronic laminitis. Am J Vet Res 2001;62:1393-1398.
36. Fielding CL, Brumbaugh GW, Matthews NS, et al. Pharmacokinetics and clinical effects of a subanesthetic continuous rate infusion of ketamine in awake horses. Am J Vet Res 2006;67:1484-1490.
37. Lankveld DP, Driessen B, Soma LR, et al. Pharmacodynamic effects and pharmacokinetic profile of a long-term continuous rate infusion of racemic ketamine in healthy conscious horses. Vet Pharmacol Ther 2006;29:477-488.
38. Hoeffer CA, Klann E. NMDA receptors and translational control. In: Van Dongen AM, ed. Biology of the NMDA receptor. Boca Raton, Fla: CRC Press, 2009.
39. Muir WW, Wade A, Grospitch B. Automatic noninvasive sphygmomanometry in horses. J Am Vet Med Assoc 1983;182:1230-1233.
40. Bailey SR, Habershon-Butcher JL, Ransom KJ, et al. Hypertension and insulin resistance in a mixed-breed population of ponies predisposed to laminitis. Am J Vet Res 2008;69:122-129.
41. Teixeira Neto FJ, McDonell WN, Black WD, et al. Effects of glycopyrrolate on cardiorespiratory function in horses anesthetized with halothane and xylazine. Am J Vet Res 2004;65:456-463.
42. Tomlinson JE, Wilder BO, Young KM, et al. Effects of flunixin meglumine or etodolac treatment on mucosal recovery of equine jejunum after ischemia. Am J Vet Res 2004;65:761-769.
43. Cook VL, Jones Shults J, McDowell MR, et al. Anti-inflammatory effects of intravenously administered lidocaine hydrochloride on ischemia-injured jejunum in horses. Am J Vet Res 2009;70:1259-1268.
44. Noschka E, Moore JN, Peroni JF, et al. Thromboxane and isoprostanes as inflammatory and vasoactive mediators in black walnut heartwood extract induced equine laminitis. Vet Immunol Immunopathol 2009;129:200-210.
45. Dhanjal JK, Wilson DV, Robinson E, et al. Intravenous tramadol: effects, nociceptive properties, and pharmacokinetics in horses. Vet Anaesth Analg 2009;36:581-590.
46. Natalini CC, Robinson EP. Evaluation of the analgesic effects of epidurally administered morphine, alfentanil, butorphanol, tramadol, and U50488H in horses. Am J Vet Res 2000;61:1579-1586.
47. Guo H, Huang LY. Alteration in the voltage dependence of NMDA receptor channels in rat dorsal horn neurones following peripheral inflammation. J Physiol 2001;537:115-123.
48. MacDonald JF, Miljkovic Z, Pennefather P. Use-dependent block of excitatory amino acid currents in cultured neurons by ketamine. J Neurophysiol 1987;58:251-266.
49. Jorum E, Warncke T, Stubhaug A. Cold allodynia and hyperalgesia in neuropathic pain: the effect of N-methyl-d-aspartate (NMDA) receptor antagonist ketamine-a double-blind, cross-over comparison with alfentanil and placebo. Pain 2003;101:229-235.
50. Exley AR, Smith N, Winer JB. Tumour necrosis factor-α and other cytokines in Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 1994;57:1118-1120.
51. Said G, Hontebeyrie-Joskowicz M. Nerve lesions induced by macrophage activation. Res Immunol 1992;143:589-599.
52. Tyor WR, Wesselingh SL, Griffin JW, et al. Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:379-388.
53. Dinarello CA. The interleukin-1 family: 10 years of discovery. FASEB J 1994;8:1314-1325.
54. Wagner R, Myers RR. Schwann cells produce tumor necrosis factor alpha: expression in injured and non-injured nerves. Neuroscience 1996;73:625-629.
55. Lankveld DP, Bull S, Van Dijk P, et al. Ketamine inhibits LPSinduced tumor necrosis factor-alpha and interleukin-6 in an equine macrophage cell line. Vet Res 2005;36:257-262.
56. Menzies-Gow NJ, Bailey SR, Katz LM, et al. Endotoxin-induced digital vasoconstriction in horses: associated changes in plasma concentrations of vasoconstrictor mediators. Equine Vet J 2004;36:273-278.
57. Bailey SR, Adair HS, Reinemeyer CR, et al. Plasma concentrations of endotoxin and platelet activation in the developmental stage of oligofructose-induced laminitis. Vet Immunol Immunopathol 2009;129:167-173.
58. Katagiri H, Ito Y, Ito S, et al. TNF-α induces thromboxane receptor signaling-dependent microcirculatory dysfunction in mouse liver. Shock 2008;30:463-467.